Total knee arthroplasty and Crigler-Najjar syndrome: A case report

Knee

Volumn 17, Issue 3, 2010, Pages 252-254

  Walmsley, David ^a   Alzaharani, Khalid ^a   Coke, William J ^b   Gandhi, Rajiv ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Crigler Najjar syndrome; Kernicterus; Osteoarthritis; Total knee arthroplasty

Indexed keywords

PHENOBARBITAL;

ADULT; ARTHROSCOPIC DEBRIDEMENT; ARTICLE; ARTICULAR CARTILAGE; CASE REPORT; CRIGLER NAJJAR SYNDROME; ENZYME THERAPY; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; KERNICTERUS; KLEBSIELLA INFECTION; KNEE PAIN; KNEE RADIOGRAPHY; MALE; PATIENT CARE; PERIOPERATIVE PERIOD; PLASMAPHERESIS; PRIORITY JOURNAL; RANGE OF MOTION; SEPSIS; SURGICAL TECHNIQUE; TOTAL KNEE REPLACEMENT;

ARTHROPLASTY, REPLACEMENT, KNEE; CRIGLER-NAJJAR SYNDROME; HUMANS; KERNICTERUS; KLEBSIELLA INFECTIONS; MALE; MIDDLE AGED; OSTEOARTHRITIS; OSTEOPHYTE; PLASMA EXCHANGE; RECOVERY OF FUNCTION; SHOCK, SEPTIC;

EID: 77952097160     PISSN: 09680160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.knee.2009.08.012     Document Type: Article

References (16)

1. Bosma P.J., Seppen J., Goldhoorn B., Bakker C., Oude Elferink R.P., Chowdhury J.R., et al. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 1994, 269:17960.
2. Jansen P.L. Diagnosis and management of Crigler-Najjar syndrome. Eur J Pediatr 1999, 158(Suppl 2):S89.
3. Cashore W.J. Kernicterus and bilirubin encephalopathy. Semin Liver Dis 1988, 8:163.
4. Brito M.A., Lima S., Fernandes A., Falcao A.S., Silva R.F., Butterfield D.A., et al. Bilirubin injury to neurons: contribution of oxidative stress and rescue by glycoursodeoxycholic acid. Neurotoxicology 2008, 29:259.
5. Vassilopoulou-Sellin R., Oyedeji C.O. Tetrapyrroles as inhibitors of normal cartilage metabolism: relative potency of different compounds. J Bone Miner Res 1988, 3:681.
6. Vassilopoulou-Sellin R., Oyedeji C.O., Samaan N.A. Bilirubin inhibits cartilage metabolism and growth in vitro. Metabolism 1989, 38:759.
7. Vassilopoulou-Sellin R., Rey-Bear N., Oyedeji C.O. Bilirubin as an inhibitor of cartilage metabolism: effect on avian chondrocyte proliferation in cell culture. J Bone Miner Res 1990, 5:769.
8. Landing B.H. Yellow-orange intervertebral disks in chronic obstructive jaundice in children. Pediatr Pathol Lab Med 1997, 17:530.
9. Hough A.J., Banfield W.G., Sokoloff L. Cartilage in hemophilic arthropathy. Ultrastructural and microanalytical studies. Arch Pathol Lab Med 1976, 100:91.
10. Robards C., Brull S.J. The anesthetic implications of Crigler-Najjar syndrome. Anesth Analg 2007, 104:435.
11. Brodersen R., Friis-Hansen B., Stern L. Drug-induced displacement of bilirubin from albumin in the newborn. Dev Pharmacol Ther 1983, 6:217.
12. Chalasani N., Chowdhury N.R., Chowdhury J.R., Boyer T.D. Kernicterus in an adult who is heterozygous for Crigler-Najjar syndrome and homozygous for Gilbert-type genetic defect. Gastroenterology 1997, 112:2099.
13. Van Thiel D.H., Lester R. Postoperative jaundice: mechanism, diagnosis, and treatment. Surg Clin North Am 1975, 55:409.
14. Field E., Hors H.M., Rubinfeld I.S., Copeland C.F., Waheed U., Jordan J., et al. Hyperbilirubinemia: a risk factor for infection in the surgical intensive care unit. Am J Surg 2008, 195:304.
15. Brito M.A., Brites D., Butterfield D.A. A link between hyperbilirubinemia, oxidative stress and injury to neocortical synaptosomes. Brain Res 2004, 1026:33.
16. Alexandra Brito M., Silva R.F., Brites D. Bilirubin toxicity to human erythrocytes: a review. Clin Chim Acta 2006, 374:46.